WEBULL
WebtradeDownload

Here's Why We're Not At All Concerned With Anterogen.Co.Ltd's (KOSDAQ:065660) Cash Burn Situation

Simply Wall St · 1d ago

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com?

Given this risk, we thought we'd take a look at whether Anterogen.Co.Ltd (KOSDAQ:065660) shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Does Anterogen.Co.Ltd Have A Long Cash Runway?

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. In June 2026, Anterogen.Co.Ltd had ₩43b in cash, and was debt-free. In the last year, its cash burn was ₩1.4b. That means it had a cash runway of very many years as of June 2026. While this is only one measure of its cash burn situation, it certainly gives us the impression that holders have nothing to worry about. You can see how its cash balance has changed over time in the image below.

debt-equity-history-analysis
KOSDAQ:A065660 Debt to Equity History October 7th 2026

See our latest analysis for Anterogen.Co.Ltd

How Well Is Anterogen.Co.Ltd Growing?

We reckon the fact that Anterogen.Co.Ltd managed to shrink its cash burn by 38% over the last year is rather encouraging. And operating revenue was up by 17% too. On balance, we'd say the company is improving over time. In reality, this article only makes a short study of the company's growth data. This graph of historic earnings and revenue shows how Anterogen.Co.Ltd is building its business over time.

How Hard Would It Be For Anterogen.Co.Ltd To Raise More Cash For Growth?

While Anterogen.Co.Ltd seems to be in a decent position, we reckon it is still worth thinking about how easily it could raise more cash, if that proved desirable. Companies can raise capital through either debt or equity. Commonly, a business will sell new shares in itself to raise cash and drive growth. By looking at a company's cash burn relative to its market capitalisation, we gain insight on how much shareholders would be diluted if the company needed to raise enough cash to cover another year's cash burn.

Anterogen.Co.Ltd's cash burn of ₩1.4b is about 0.9% of its ₩162b market capitalisation. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply.

So, Should We Worry About Anterogen.Co.Ltd's Cash Burn?

It may already be apparent to you that we're relatively comfortable with the way Anterogen.Co.Ltd is burning through its cash. For example, we think its cash runway suggests that the company is on a good path. Its revenue growth wasn't quite as good, but was still rather encouraging! Looking at all the measures in this article, together, we're not worried about its rate of cash burn; the company seems well on top of its medium-term spending needs. An in-depth examination of risks revealed 1 warning sign for Anterogen.Co.Ltd that readers should think about before committing capital to this stock.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts)